SAH-induced cerebral vasospasm: Unraveling molecular mechanisms of a complex disease

Stroke

Volumn 34, Issue 2, 2003, Pages 432-433

  Bhardwaj, Anish ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; MITOGENIC AGENT; PLATELET DERIVED GROWTH FACTOR AB; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANIMAL TESTING REFINEMENT; ANIMAL USE; ARTERY INTIMA; ARTERY MEDIA; BRAIN ARTERY; BRAIN VASOSPASM; CULTURE MEDIUM; DISEASE MARKER; DISEASE MODEL; DISEASE SIMULATION; HUMAN; NEUROPROTECTION; NONHUMAN; NOTE; PATHOGENESIS; PEER REVIEW; PRIORITY JOURNAL; RISK FACTOR; SUBARACHNOID HEMORRHAGE;

EID: 0037319240     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T, Truskowski L, Tomer JC. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Crit Care Med. 1995;23:1007-1017.
2. Dietrich HH, Dacey RG Jr. Molecular keys to the problems of cerebral vasospasm. Neurosurgery. 2000;46:517-530.
3. Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol. 2002;88:227-249.
4. Gabikian P, Clatterbuck RE, Eberhart CG, Tyler BM, Tierney TS, Tamargo RJ. Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats. Stroke. 2002;33:2681-2686.
5. Thai Q-A, Oshiro EM, Tamargo RJ. Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers. Stroke. 1999;30:140-147.
6. Clatterbuck RE, Oshiro EM, Hoffman PA, Dietsch GN, Padroll DM, Tamargo RJ. Inhibition of vasospasm with lymphocyte functionassociated antigen-1 monoclonal antibody in a femoral artery, model of rats. J Neurosurg. 2002;97:676-682.
7. Ono S, Komuro T, Macdonald RL. Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J Neurosurg. 2002;96:1094-1102.
8. Megyesi JF, Vollrath B, Cook DA, Findlay JM. In vivo animal models of cerebral vasospasm: a review. Neurosurgery. 2000;46:448-461.
9. Borel CO, McKee A, Parra A, Haglund MH, Solan A, Prabhakar V, Shen H, Warner DS, Niklason L. A possible role for vascular cell proliferation in cerebral vasospasm following subarachnoid hemorrhage. Stroke. 2003;34:427-433.
10. Hirashima Y, Endo S, Nukui H, Kobayashi N, Takaku A. Effect of a platelet-activating factor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: open clinical trial to investigate efficacy and safety. Neurol Med Chir (Tokyo). 2001;41:165-175.